3D bioprinted organ-on-chips

dc.contributor.authorid0000-0003-4604-217X
dc.contributor.authorid0009-0004-1518-6706
dc.contributor.authorid0000-0002-5295-5701
dc.contributor.authorid0000-0001-8888-6106
dc.contributor.coauthorMustafaoglu, Nur
dc.contributor.coauthorZhang, Yu Shrike
dc.contributor.departmentDepartment of Electrical and Electronics Engineering
dc.contributor.departmentN/A
dc.contributor.departmentN/A
dc.contributor.departmentN/A
dc.contributor.kuauthorTaşoğlu, Savaş
dc.contributor.kuauthorBirtek, Mehmet Tuğrul
dc.contributor.kuauthorSarabi, Misagh Rezapour
dc.contributor.kuauthorDabbagh, Sajjad Rahmani
dc.contributor.kuprofileFaculty Member
dc.contributor.kuprofilePhD Student
dc.contributor.kuprofilePhD Student
dc.contributor.kuprofilePhD Student
dc.contributor.researchcenterKoç Üniversitesi İş Bankası Yapay Zeka Uygulama ve Araştırma Merkezi (KUIS AI)/ Koç University İş Bank Artificial Intelligence Center (KUIS AI)
dc.contributor.researchcenterKU Arçelik Research Center for Creative Industries (KUAR) / KU Arçelik Yaratıcı Endüstriler Uygulama ve Araştırma Merkezi (KUAR)
dc.contributor.schoolcollegeinstituteCollege of Engineering
dc.contributor.schoolcollegeinstituteGraduate School of Sciences and Engineering
dc.contributor.schoolcollegeinstituteGraduate School of Sciences and Engineering
dc.contributor.schoolcollegeinstituteGraduate School of Sciences and Engineering
dc.contributor.yokid291971
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.contributor.yokidN/A
dc.date.accessioned2025-01-19T10:33:57Z
dc.date.issued2023
dc.description.abstractOrgan-on-a-chip (OOC) platforms recapitulate human in vivo-like conditions more realistically compared to many animal models and conventional two-dimensional cell cultures. OOC setups benefit from continuous perfusion of cell cultures through microfluidic channels, which promotes cell viability and activities. Moreover, microfluidic chips allow the integration of biosensors for real-time monitoring and analysis of cell interactions and responses to administered drugs. Three-dimensional (3D) bioprinting enables the fabrication of multicell OOC platforms with sophisticated 3D structures that more closely mimic human tissues. 3D-bioprinted OOC platforms are promising tools for understanding the functions of organs, disruptive influences of diseases on organ functionality, and screening the efficacy as well as toxicity of drugs on organs. Here, common 3D bioprinting techniques, advantages, and limitations of each method are reviewed. Additionally, recent advances, applications, and potentials of 3D-bioprinted OOC platforms for emulating various human organs are presented. Last, current challenges and future perspectives of OOC platforms are discussed. © 2022 The Authors. Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.issue1
dc.description.openaccessAll Open Access; Green Open Access
dc.description.publisherscopeInternational
dc.description.sponsorsFunding text 1: S. T. acknowledges Tubitak 2232 International Fellowship for Outstanding Researchers Award (118C391), Alexander von Humboldt Research Fellowship for Experienced Researchers, Marie Skłodowska-Curie Individual Fellowship (101003361), and Royal Academy Newton-Katip Çelebi Transforming Systems Through Partnership award (120N019) for financial support of this research. This work was partially supported by Science Academy's Young Scientist Awards Program (BAGEP), Outstanding Young Scientists Awards (GEBİP), and Bilim Kahramanlari Dernegi The Young Scientist Award. N. M. acknowledges Marie Skłodowska-Curie Individual Fellowship (101038093). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. YSZ acknowledges the support by the Brigham Research Institute. Some elements in Figure 1 have been designed using resources from Flaticon.com.; Funding text 2: S. T. acknowledges Tubitak 2232 International Fellowship for Outstanding Researchers Award (118C391), Alexander von Humboldt Research Fellowship for Experienced Researchers, Marie Skłodowska‐Curie Individual Fellowship (101003361), and Royal Academy Newton‐Katip Çelebi Transforming Systems Through Partnership award (120N019) for financial support of this research. This work was partially supported by Science Academy's Young Scientist Awards Program (BAGEP), Outstanding Young Scientists Awards (GEBİP), and Bilim Kahramanlari Dernegi The Young Scientist Award. N. M. acknowledges Marie Skłodowska‐Curie Individual Fellowship (101038093). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. YSZ acknowledges the support by the Brigham Research Institute. Some elements in Figure 1 have been designed using resources from Flaticon.com.
dc.description.volume4
dc.identifier.doi10.1002/agt2.197
dc.identifier.issn27668541
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85166390021
dc.identifier.urihttps://doi.org/10.1002/agt2.197
dc.identifier.urihttps://hdl.handle.net/20.500.14288/26688
dc.identifier.wos789167900001
dc.keywordsBiomaterials
dc.keywordsBioprinting
dc.keywordsDisease-on-a-chip
dc.keywordsMicrofluidics
dc.keywordsOrgan-on-a-chip
dc.languageen
dc.publisherJohn Wiley and Sons Inc
dc.relation.grantnoBilim Kahramanlari Dernegi; Royal Academy, (120N019); Alexander von Humboldt-Stiftung, AvH, (101003361); Brigham Research Institute, BRI; H2020 Marie Skłodowska-Curie Actions, MSCA, (101038093); Bilim Akademisi
dc.sourceAggregate
dc.subjectElectrical and electronics engineering
dc.title3D bioprinted organ-on-chips
dc.typeReview

Files